Lotel Eye Ointment contains Loteprednol etabonate 5 mg, a corticosteroid indicated for the treatment of inflammatory conditions of the eye. Loteprednol etabonate is a synthetic glucocorticoid with potent anti-inflammatory properties, designed to reduce ocular inflammation and associated symptoms such as redness, swelling, and discomfort. This ophthalmic ointment is primarily prescribed for conditions including allergic conjunctivitis, postoperative inflammation following ocular surgery, and other inflammatory disorders of the anterior segment of the eye. The formulation allows for sustained drug contact with the ocular surface, enhancing therapeutic efficacy while minimizing systemic absorption. Loteprednol etabonate exerts its effect by inhibiting multiple inflammatory mediators and cellular responses involved in the inflammatory cascade. It is generally well tolerated; however, prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary ocular infections. Therefore, Lotel Eye Ointment should be used under strict medical supervision with regular monitoring of intraocular pressure. Patients should avoid contact lens use during treatment unless otherwise advised. This medication is contraindicated in viral, fungal, or mycobacterial ocular infections. Lotel Eye Ointment offers a targeted approach to managing ocular inflammation, improving patient comfort and visual outcomes when used appropriately.